No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users.
about
Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV InfectionsPolymorphisms in the regulatory region of the Cyclophilin A gene influence the susceptibility for HIV-1 infectionCCR5 haplotypes and mother-to-child HIV transmission in Malawi.A whole genome association study of mother-to-child transmission of HIV in Malawi.Some aspects of the natural history of HIV infection.Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapyAssociation of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians.Distribution of CCR5-Delta32, CCR5 promoter 59029 A/G, CCR2-64I and SDF1-3'A genetic polymorphisms in HIV-1 infected and uninfected patients in the west region of CameroonChemokine Coreceptor-2 Gene Polymorphisms among HIV-1 Infected Individuals in KenyaHost factors influencing susceptibility to HIV infection and AIDS progression.Global human genetics of HIV-1 infection and China.Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic ApproachesCoregulation of HIV-1 dependency factors in individuals heterozygous to the CCR5-delta32 deletion.Social and structural factors associated with HIV disease progression among illicit drug users: a systematic reviewThe effect of combined polymorphisms in chemokines and chemokine receptors on the clinical course of HIV-1 infection in a Brazilian population.The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia.Lack of effect of chemokine receptor CCR2b gene polymorphism (64I) on HIV-1 plasma RNA viral load and immune activation among HIV-1 seropositive female workers in Abidjan, Côte d'Ivoire.
P2860
Q26768628-20D34F17-E7EC-4095-A1EF-527D6807024CQ28474342-0E5B4970-4BE7-493F-BFA3-0DD580CEE0F7Q33296998-018EB6A1-15EF-4AC0-8750-DBA7EF39AD6EQ33865715-58D9A768-68F7-4ADB-81A9-D5090712335CQ34018002-D4D0D1D4-0675-4B24-9B4B-961B7879A888Q34357979-DF94EF90-3738-4233-92E0-2900EF0EA5FBQ34736406-DAD785C9-164D-45BB-8125-AE857CECF0D8Q34785274-05845819-C670-4B2D-A942-09674DED778CQ34860765-6A1CA255-5467-459E-B989-C9A6BB06499BQ35957789-4173C512-E8CC-4091-815B-6A45B467121CQ35995936-D933A0F6-82B3-4B92-93B2-7353E19B2C04Q36342033-412A583E-B29B-4594-A9CC-DCFF5E3AB06CQ37252004-672E4582-C769-4481-B076-55FB9C435AB7Q37326697-FA5CD7F0-D5F8-44B9-A73E-FB952B32FADBQ37638817-490C7DEE-7263-454F-B831-6F0BDF9B672CQ44873706-512E6997-ACE8-407A-AE4F-4EF02DA7AC04Q45211606-4648E7A1-CF1F-4521-866A-E0CFF144513FQ46199960-7B414C69-066A-4052-A0D8-3AAC9EC45B34
P2860
No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
No evidence for an effect of t ...... infected injecting drug users.
@en
No evidence for an effect of t ...... n human immunodeficiency virus
@nl
type
label
No evidence for an effect of t ...... infected injecting drug users.
@en
No evidence for an effect of t ...... n human immunodeficiency virus
@nl
prefLabel
No evidence for an effect of t ...... infected injecting drug users.
@en
No evidence for an effect of t ...... n human immunodeficiency virus
@nl
P2093
P356
P1476
No evidence for an effect of t ...... infected injecting drug users.
@en
P2093
Coutinho RA
Langendam MW
Schinkel J
Schuitemaker H
P304
P356
10.1086/314658
P407
P577
1999-04-01T00:00:00Z